Patent · US Active

Endostatin fragments and variants for use in treating fibrosis

US11912755B2 · kind B2 · utility

0Cited by
31References
4Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 9, 2020
Grant dateFeb 27, 2024
Priority date
Expiry dateNov 9, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Materials and methods for using polypeptides containing fragments and variants of endostatin to treat fibrosis are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.